Download or view AmStem Investor Presentation January 2010
"Fulfilling the worldwide promise of stem cells"
| About AmStem International |
|
|
|
About Stem Cell Therapy International, Inc.Stem Cell Therapy International, Inc. (OTC; AMST) is in the field of regenerative medicine. AMST is a company devoted to the treatment of patients with stem cell transplantation therapy as well as providing the supplies of biological solutions containing new lines of stem cell products. About AmStem International, Inc.AmStem is a new biotechnology company based in Northern California, in the watershed of stem cell innovation fueled by President Obama’s recent announcement to lift Federal funding limitations for stem cell research. AmStem provides biotherapeutic and cosmetic stem cell products, stem cell collection and storage know-how, and access to nanotechnology vital to cutting edge stem cell research. About Histostem Corporation, Ltd.Histostem is owned 90% by AMST. Founded in Seoul, Korea in 2000, to date it has treated more than 500 patients with stem cells and currently has 56 full-time employees and 28 part-time employees. Histostem's intellectual property portfolio consists of six patents that have been granted and 5 patents pending. To its knowledge Histostem is one of the very few stem cell companies in the world currently earning several million dollars in income from its products and technology. A comprehensive list of Histostem's achievements can be found at the company’s website http://www.histostem.co.kr (click on English version when entering the site). Three Pillars of HistoStem / AmStem International
|